Worries About Job Losses Increase The Chances Of Heart Attack And Stroke.
Women who have taxing jobs with toy supervision over their busy days are at higher danger for heart attacks or the need for coronary bypass surgery, new on suggests. Furthermore, worrying about losing one's job also raised the odds of having cardiovascular bug risk factors such as high blood pressure and higher cholesterol levels - but not present heart attacks, stroke or death, the researchers said. The study, presented Sunday at the annual meet of the American Heart Association in Chicago, breaks new turf for being one of the first to look at the effect of work-related stress on women's health.
Most previous studies have focused on men and, yes, those studies found that problem stress upped males' odds for cardiovascular disease, too. Women comprise inefficiently half of the US workforce today, with 70 percent of all women holding some benevolent of job, said study senior author Dr Michelle A Albert, an associate physician at Brigham and Women's Hospital in Boston. Albert and her colleagues looked at more than 17000 female trim professionals, with an average age of 57, who showed no signs of cardiovascular ailment at the beginning of the study.
Participants responded to statements about how draining their job was, such as - "My proceeding allows me to make a lot of decisions on my own" or "My job requires that I master new things" or "My job requires working very fast. Job strain involving intellectual demand and decision latitude are tied into the concept of skill, how you are allowed to be at your job, is your contribution repetitive, does it require you to work at a fast pace".
Over 10 years of follow-up, the researchers distinguished that women with high job strain - demanding jobs over which they had little control - were more meet to be sedentary and to have high cholesterol. They were also at almost double the risk for a heart attack and at a 43 percent higher peril to undergo a bypass procedure. The researchers found no significant link between role strain and either stroke or risk for death.
Monday 13 March 2017
The Problem Of Treating Patients With Heart Disease Who Do Not Respond To Plavix
The Problem Of Treating Patients With Heart Disease Who Do Not Respond To Plavix.
Higher doses of the blood-thinner Plavix were no better at preventing empathy attacks, blood clots or passing than the recognized lower dose in patients who had received artery-opening stents, late research shows. The higher dose - double-barrelled the usual amount - was tested in patients with "high platelet reactivity," meaning they failed to counter to the drug at lower doses. Plavix (clopidogrel) helps prevent clots from forming in patients who have gloomy platelet reactivity and who have had stents inserted to prop open blocked arteries.
But the further study "doesn't support" physicians using the higher, 150-milligram dose of Plavix after stenting, according to enquiry lead author Dr Matthew Price, who presented the findings Tuesday at the annual encounter of the American Heart Association in Chicago. So, the study leaves an important question unanswered: How to entertain heart patients who don't respond well to Plavix? "It remains variable to some extent," said Dr Abhiram Prasad, an interventional cardiologist with the Mayo Clinic in Rochester, Minn. "It's an conspicuous study to have done but the key issues are that a significant proportion of the patients remained with serious platelet reactivity even after being on the higher dose".
Previous, smaller studies had indicated that Plavix might have more of an effect if the amount was doubled. "Platelet reactivity varies widely," noted Price, director of the Cardiac Catheterization Laboratory at the Scripps Clinic in La Jolla, Calif. He explained that numerous studies have shown that a squiffy reactivity plane is associated with poorer outcomes after angioplasty and/or stenting. But until now, a sharp rise in the dose of Plavix "has not been tested in a large randomized clinical trial".
Higher doses of the blood-thinner Plavix were no better at preventing empathy attacks, blood clots or passing than the recognized lower dose in patients who had received artery-opening stents, late research shows. The higher dose - double-barrelled the usual amount - was tested in patients with "high platelet reactivity," meaning they failed to counter to the drug at lower doses. Plavix (clopidogrel) helps prevent clots from forming in patients who have gloomy platelet reactivity and who have had stents inserted to prop open blocked arteries.
But the further study "doesn't support" physicians using the higher, 150-milligram dose of Plavix after stenting, according to enquiry lead author Dr Matthew Price, who presented the findings Tuesday at the annual encounter of the American Heart Association in Chicago. So, the study leaves an important question unanswered: How to entertain heart patients who don't respond well to Plavix? "It remains variable to some extent," said Dr Abhiram Prasad, an interventional cardiologist with the Mayo Clinic in Rochester, Minn. "It's an conspicuous study to have done but the key issues are that a significant proportion of the patients remained with serious platelet reactivity even after being on the higher dose".
Previous, smaller studies had indicated that Plavix might have more of an effect if the amount was doubled. "Platelet reactivity varies widely," noted Price, director of the Cardiac Catheterization Laboratory at the Scripps Clinic in La Jolla, Calif. He explained that numerous studies have shown that a squiffy reactivity plane is associated with poorer outcomes after angioplasty and/or stenting. But until now, a sharp rise in the dose of Plavix "has not been tested in a large randomized clinical trial".
Spread Of Menthol Cigarettes Among Young People
Spread Of Menthol Cigarettes Among Young People.
The engagement over menthol-flavored cigarettes heats up again Thursday as a US Food and Drug Administration warning panel continues a series of hearings on whether to debar the cigarettes. The FDA's Tobacco Products Scientific Advisory Committee consists of nine members and includes doctors, scientists and notorious fettle experts. The tobacco industry is represented by three non-voting members. The body has until next March to report its menthol findings to the US Secretary of Health and Human Services.
Much of the argumentation centers on research that shows that children are particularly drawn to menthol cigarettes, with nearly 45 percent of smokers superannuated 12 to 17 using them, according to a 2009 National Survey on Drug Use and Health. Most unprincipled teenaged smokers - and 82,7 percent of black full-grown smokers - favor menthols, the same survey found. "The manufacturers would have you believe there is not a scintilla of demonstrate that menthol is more dangerous than other cigarettes to the individual smoker, but we do not agree," said Ellen Vargyas, habitual counsel for the American Legacy Foundation, a smoking prevention and cessation organization in Washington, DC, founded with funding from the watershed 1998 Master Settlement Agreement between the tobacco enterprise and state governments.
And "Over 80 percent of African-American smokers smoke menthol, and African-American smokers have the highest rates of lung cancer. We also distinguish African-Americans with lung cancer are more apt to to die from lung cancer," she told HealthDay. In addition, the popularity of menthols among younger, newer smokers suggests that maybe the minty taste does encourage subjects to start, perhaps by masking the harsh taste of regular cigarettes. "We know the younger you are and the newer the smoker you are, the more expected you are to smoke menthol. There is a very strong correlation between being a teenaged smoker and menthol cigarettes".
That's no coincidence, for example smoking opponents: The tobacco earnestness has long targeted youth and minorities for menthol cigarette marketing, even manipulating menthol import in different brands in an effort to recruit new smokers among youth, according to the US National Cancer Institute and the Harvard School of Public Health. The contend over how menthols should be regulated was endure discussed in July, during the second round of hearings held by the tobacco products advisory committee.
The engagement over menthol-flavored cigarettes heats up again Thursday as a US Food and Drug Administration warning panel continues a series of hearings on whether to debar the cigarettes. The FDA's Tobacco Products Scientific Advisory Committee consists of nine members and includes doctors, scientists and notorious fettle experts. The tobacco industry is represented by three non-voting members. The body has until next March to report its menthol findings to the US Secretary of Health and Human Services.
Much of the argumentation centers on research that shows that children are particularly drawn to menthol cigarettes, with nearly 45 percent of smokers superannuated 12 to 17 using them, according to a 2009 National Survey on Drug Use and Health. Most unprincipled teenaged smokers - and 82,7 percent of black full-grown smokers - favor menthols, the same survey found. "The manufacturers would have you believe there is not a scintilla of demonstrate that menthol is more dangerous than other cigarettes to the individual smoker, but we do not agree," said Ellen Vargyas, habitual counsel for the American Legacy Foundation, a smoking prevention and cessation organization in Washington, DC, founded with funding from the watershed 1998 Master Settlement Agreement between the tobacco enterprise and state governments.
And "Over 80 percent of African-American smokers smoke menthol, and African-American smokers have the highest rates of lung cancer. We also distinguish African-Americans with lung cancer are more apt to to die from lung cancer," she told HealthDay. In addition, the popularity of menthols among younger, newer smokers suggests that maybe the minty taste does encourage subjects to start, perhaps by masking the harsh taste of regular cigarettes. "We know the younger you are and the newer the smoker you are, the more expected you are to smoke menthol. There is a very strong correlation between being a teenaged smoker and menthol cigarettes".
That's no coincidence, for example smoking opponents: The tobacco earnestness has long targeted youth and minorities for menthol cigarette marketing, even manipulating menthol import in different brands in an effort to recruit new smokers among youth, according to the US National Cancer Institute and the Harvard School of Public Health. The contend over how menthols should be regulated was endure discussed in July, during the second round of hearings held by the tobacco products advisory committee.
Friday 10 March 2017
Lung Cancer Remains The Most Lethal Cancer
Lung Cancer Remains The Most Lethal Cancer.
New recommendations from the American Cancer Society about that older in touch or former heavy smokers may want to look upon low-dose CT scans to help screen for lung cancer. Specifically, that includes those old 55 to 74 with a 30 pack-year smoking history who still smoke or who had quit within the past 15 years. Pack-years are a amount made by multiplying the number of packs of cigarettes smoked a epoch by the number of years of smoking. "Even with screening, lung cancer would remain the most lethal cancer," said Dr Norman Edelman, supervisor medical officer at the American Lung Association.
He esteemed the cancer society guidelines are similar to the ones from the lung association. The restored recommendation follows on the results of a major US National Cancer Institute study, published in 2010 in Radiology, that found that annual CT screening for lung cancer for older inclination or old smokers cut their death rate by 20 percent.
Edelman stressed that the study does nothing to change the episode that smoking prevention and cessation remain the most important public health challenge there is. "Screening is not a velocity to make smoking safe from cancer deaths, and certainly does nothing to prevent smoking-related deaths from lasting obstructive pulmonary disease and heart disease".
The cancer society recommendations also highlight smoking cessation counseling as a high priority and stress that CT screening is not an alternative to quitting smoking. CT screening should only be done after a colloquy between patients and their doctors so people fully understand the benefits, limitations and risks of screening. In addition, screening should only be done by someone efficient in low-dose CT lung cancer screening, the cancer organization stressed.
New recommendations from the American Cancer Society about that older in touch or former heavy smokers may want to look upon low-dose CT scans to help screen for lung cancer. Specifically, that includes those old 55 to 74 with a 30 pack-year smoking history who still smoke or who had quit within the past 15 years. Pack-years are a amount made by multiplying the number of packs of cigarettes smoked a epoch by the number of years of smoking. "Even with screening, lung cancer would remain the most lethal cancer," said Dr Norman Edelman, supervisor medical officer at the American Lung Association.
He esteemed the cancer society guidelines are similar to the ones from the lung association. The restored recommendation follows on the results of a major US National Cancer Institute study, published in 2010 in Radiology, that found that annual CT screening for lung cancer for older inclination or old smokers cut their death rate by 20 percent.
Edelman stressed that the study does nothing to change the episode that smoking prevention and cessation remain the most important public health challenge there is. "Screening is not a velocity to make smoking safe from cancer deaths, and certainly does nothing to prevent smoking-related deaths from lasting obstructive pulmonary disease and heart disease".
The cancer society recommendations also highlight smoking cessation counseling as a high priority and stress that CT screening is not an alternative to quitting smoking. CT screening should only be done after a colloquy between patients and their doctors so people fully understand the benefits, limitations and risks of screening. In addition, screening should only be done by someone efficient in low-dose CT lung cancer screening, the cancer organization stressed.
The United States Ranks Last Compared With The Six Other Industrialized Countries
The United States Ranks Last Compared With The Six Other Industrialized Countries.
Compared with six other industrialized nations, the United States ranks wear when it comes to many measures of blue blood salubrity care, a new report concludes. Despite having the costliest vigour care system in the world, the United States is last or next-to-last in quality, efficiency, access to care, high-mindedness and the ability of its citizens to lead long, healthy, dynamic lives, according to a new report from the Commonwealth Fund, a Washington, DC-based private cellar focused on improving health care. "On many measures of health system performance, the US has a hanker way to go to perform as well as other countries that spend far less than we do on healthcare, yet cover everyone," the Commonwealth Fund's president, Karen Davis, said during a Tuesday matutinal teleconference.
And "It is disappointing, but not surprising, that regardless of our significant investment in health care, the US continues to lag behind other countries". However, Davis believes rejuvenated health care reform legislation - when fully enacted in 2014 - will go a elongate way to improving the current system. "Our hope and expectation is that when the measure is fully enacted, we will match and even exceed the performance of other countries".
The report compares the performance of the American vigorousness care system with those of Australia, Canada, Germany, the Netherlands, New Zealand and the United Kingdom. According to 2007 facts included in the report, the US spends the most on health care, at $7,290 per capita per year. That's almost twice the bulk spent in Canada and nearly three times the compute of New Zealand, which spends the least.
The Netherlands, which has the highest-ranked robustness care system on the Commonwealth Fund list, spends only $3,837 per capita. Despite higher spending, the US ranks most recent or next to last in all categories and scored "particularly inexpertly on measures of access, efficiency, equity and long, healthy and productive lives".
The US ranks in the mid-point of the pack in measures of effective and patient-centered care. Overall, the Netherlands came in first on the list, followed by the United Kingdom and Australia. Canada and the United States ranked sixth and seventh.
Speaking at the teleconference, Cathy Schoen, major failing president at the Commonwealth Fund, pointed out that in 2008, 14 percent of US patients with hardened conditions had been given the wrong medication or the wrong dose. That's twice the indiscretion rate observed in Germany and the Netherlands.
Compared with six other industrialized nations, the United States ranks wear when it comes to many measures of blue blood salubrity care, a new report concludes. Despite having the costliest vigour care system in the world, the United States is last or next-to-last in quality, efficiency, access to care, high-mindedness and the ability of its citizens to lead long, healthy, dynamic lives, according to a new report from the Commonwealth Fund, a Washington, DC-based private cellar focused on improving health care. "On many measures of health system performance, the US has a hanker way to go to perform as well as other countries that spend far less than we do on healthcare, yet cover everyone," the Commonwealth Fund's president, Karen Davis, said during a Tuesday matutinal teleconference.
And "It is disappointing, but not surprising, that regardless of our significant investment in health care, the US continues to lag behind other countries". However, Davis believes rejuvenated health care reform legislation - when fully enacted in 2014 - will go a elongate way to improving the current system. "Our hope and expectation is that when the measure is fully enacted, we will match and even exceed the performance of other countries".
The report compares the performance of the American vigorousness care system with those of Australia, Canada, Germany, the Netherlands, New Zealand and the United Kingdom. According to 2007 facts included in the report, the US spends the most on health care, at $7,290 per capita per year. That's almost twice the bulk spent in Canada and nearly three times the compute of New Zealand, which spends the least.
The Netherlands, which has the highest-ranked robustness care system on the Commonwealth Fund list, spends only $3,837 per capita. Despite higher spending, the US ranks most recent or next to last in all categories and scored "particularly inexpertly on measures of access, efficiency, equity and long, healthy and productive lives".
The US ranks in the mid-point of the pack in measures of effective and patient-centered care. Overall, the Netherlands came in first on the list, followed by the United Kingdom and Australia. Canada and the United States ranked sixth and seventh.
Speaking at the teleconference, Cathy Schoen, major failing president at the Commonwealth Fund, pointed out that in 2008, 14 percent of US patients with hardened conditions had been given the wrong medication or the wrong dose. That's twice the indiscretion rate observed in Germany and the Netherlands.
Wednesday 8 March 2017
An Effect Of Hormone Therapy On Breast Cancer
An Effect Of Hormone Therapy On Breast Cancer.
Although several overweight studies in latest years have linked the use of hormone therapy after menopause with an increased danger of breast cancer, the authors of a new analysis claim the evidence is too limited to confirm the connection. Dr Samuel Shapiro, of the University of Cape Town Medical School in South Africa, and his colleagues took another air at three eminently studies that investigated hormone therapy and its credible health risks - the Collaborative Reanalysis, the Women's Health Initiative (WHI) and the Million Women Study. Together, the results of these studies found overall an increased jeopardize of breast cancer centre of women who used the combination form of hormone therapy with both estrogen and progesterone.
Women who have had a hysterectomy and use estrogen-only group therapy also have an increased risk, two of the studies found. The WHI, however, found that estrogen-only remedy may not increase breast cancer risk and may actually decrease it, although that has not been confirmed in other research. After the WHI scrutinize was published in July 2002, women dropped hormone cure in droves.
Many experts pointed to that decline in hormone therapy use as the reason breast cancer rates were declining. Not so, Shapiro said: "The declivity in breast cancer extent started three years before the fall in HRT use commenced, lasted for only one year after the HRT dab commenced, and then stopped". For instance between 2002 and 2003, when large numbers of women were still using hormone therapy, the numeral of new breast cancer cases fell by nearly 7 percent.
In taking a bearing at the three studies again, Shapiro and his team reviewed whether the evidence satisfied criteria superior to researchers, such as the strength of an association, taking into account other factors that could influence risk. Their conclusion: The fact is not strong enough to say definitively that hormone therapy causes breast cancer. The go into is published in the current issue of the Journal of Family Planning and Reproductive Health Care.
Although several overweight studies in latest years have linked the use of hormone therapy after menopause with an increased danger of breast cancer, the authors of a new analysis claim the evidence is too limited to confirm the connection. Dr Samuel Shapiro, of the University of Cape Town Medical School in South Africa, and his colleagues took another air at three eminently studies that investigated hormone therapy and its credible health risks - the Collaborative Reanalysis, the Women's Health Initiative (WHI) and the Million Women Study. Together, the results of these studies found overall an increased jeopardize of breast cancer centre of women who used the combination form of hormone therapy with both estrogen and progesterone.
Women who have had a hysterectomy and use estrogen-only group therapy also have an increased risk, two of the studies found. The WHI, however, found that estrogen-only remedy may not increase breast cancer risk and may actually decrease it, although that has not been confirmed in other research. After the WHI scrutinize was published in July 2002, women dropped hormone cure in droves.
Many experts pointed to that decline in hormone therapy use as the reason breast cancer rates were declining. Not so, Shapiro said: "The declivity in breast cancer extent started three years before the fall in HRT use commenced, lasted for only one year after the HRT dab commenced, and then stopped". For instance between 2002 and 2003, when large numbers of women were still using hormone therapy, the numeral of new breast cancer cases fell by nearly 7 percent.
In taking a bearing at the three studies again, Shapiro and his team reviewed whether the evidence satisfied criteria superior to researchers, such as the strength of an association, taking into account other factors that could influence risk. Their conclusion: The fact is not strong enough to say definitively that hormone therapy causes breast cancer. The go into is published in the current issue of the Journal of Family Planning and Reproductive Health Care.
Thursday 2 March 2017
Doctors Discovered A Link Between Alcoholism And Obesity
Doctors Discovered A Link Between Alcoholism And Obesity.
People at higher endanger for alcoholism might also impression higher odds of becoming obese, new contemplate findings show. Researchers at Washington University School of Medicine in St Louis analyzed material from two large US alcoholism surveys conducted in 1991-1992 and 2001-2002. According to the results of the more fresh survey, women with a family history of alcoholism were 49 percent more liable to to be obese than other women. Men with a family history of alcoholism were also more likely to be obese, but this association was not as offensively in men as in women, said first author Richard A Grucza, an assistant professor of psychiatry.
One exegesis for the increased risk of obesity among people with a family history of alcoholism could be that some masses substitute one addiction for another. For example, after a person sees a close allied with a drinking problem, they may avoid alcohol but consume high-calorie foods that stimulate the same reward centers in the perception that react to alcohol, Grucza suggested.
In their analysis of the data from both surveys, the researchers found that the element between family history of alcoholism and obesity has grown stronger over time. This may be due to the increasing availability of foods that interact with the same percipience areas as alcohol.
People at higher endanger for alcoholism might also impression higher odds of becoming obese, new contemplate findings show. Researchers at Washington University School of Medicine in St Louis analyzed material from two large US alcoholism surveys conducted in 1991-1992 and 2001-2002. According to the results of the more fresh survey, women with a family history of alcoholism were 49 percent more liable to to be obese than other women. Men with a family history of alcoholism were also more likely to be obese, but this association was not as offensively in men as in women, said first author Richard A Grucza, an assistant professor of psychiatry.
One exegesis for the increased risk of obesity among people with a family history of alcoholism could be that some masses substitute one addiction for another. For example, after a person sees a close allied with a drinking problem, they may avoid alcohol but consume high-calorie foods that stimulate the same reward centers in the perception that react to alcohol, Grucza suggested.
In their analysis of the data from both surveys, the researchers found that the element between family history of alcoholism and obesity has grown stronger over time. This may be due to the increasing availability of foods that interact with the same percipience areas as alcohol.
Good Health Of The Heart Protects Against Alzheimer's Disease
Good Health Of The Heart Protects Against Alzheimer's Disease.
Sticking to a heart-healthy lifestyle may also quarter off Alzheimer's disease, according to a late study that suggests that raising "good" cholesterol levels can helper prevent the brain disorder in older people. The study, published in the December edition of Archives of Neurology, found that people who had low levels of high-density lipoprotein (HDL) or "good" cholesterol had a 60 percent greater endanger of developing Alzheimer's blight after the age of 65 than those who had high levels. Cholesterol is a waxy substance composed of "good and bad" cholesterol and triglycerides found in the bloodstream.
More than 50 percent of the US citizens has high levels of "bad" cholesterol, according to the study. "Our memorize suggests that high HDL levels 'good' cholesterol are associated with a decrease risk for Alzheimer's disease," said Dr Christiane Reitz, the study's author. "Ways to enhancement HDL levels include losing weight if overweight, aerobic irritate and a healthy diet".
By treating problems with cholesterol levels, "we can debase the incidence of Alzheimer's disease in the population". Some medications, such as statins, fibrates and niacin, that are in use to lower "bad" cholesterol also raise "good" cholesterol an assistant professor of neurology at Columbia University's Taub Institute for Research on Alzheimer's Disease in New York City. More than 5 million Americans have Alzheimer's disease, the most banal ceremony of dementia, and those numbers could triple by 2050, according to vigorousness officials.
The US National Institutes of Health reports that about 5 percent of Americans between the ages of 65 and 74 have late-onset Alzheimer's disease, the more commonplace form of the disorder, and the control increases with age. By age 85, nearly 50 percent of the population develops the disease, according to the agency.
Early-onset Alzheimer's, a excellent form of the disease, begins in middle age and runs in families. Late-onset Alzheimer's has a genetic component influenced by lifestyle factors, according to the agency. There is no prescription for Alzheimer's disease, but a few drugs can hand reduce symptoms for a time, according to experts.
Sticking to a heart-healthy lifestyle may also quarter off Alzheimer's disease, according to a late study that suggests that raising "good" cholesterol levels can helper prevent the brain disorder in older people. The study, published in the December edition of Archives of Neurology, found that people who had low levels of high-density lipoprotein (HDL) or "good" cholesterol had a 60 percent greater endanger of developing Alzheimer's blight after the age of 65 than those who had high levels. Cholesterol is a waxy substance composed of "good and bad" cholesterol and triglycerides found in the bloodstream.
More than 50 percent of the US citizens has high levels of "bad" cholesterol, according to the study. "Our memorize suggests that high HDL levels 'good' cholesterol are associated with a decrease risk for Alzheimer's disease," said Dr Christiane Reitz, the study's author. "Ways to enhancement HDL levels include losing weight if overweight, aerobic irritate and a healthy diet".
By treating problems with cholesterol levels, "we can debase the incidence of Alzheimer's disease in the population". Some medications, such as statins, fibrates and niacin, that are in use to lower "bad" cholesterol also raise "good" cholesterol an assistant professor of neurology at Columbia University's Taub Institute for Research on Alzheimer's Disease in New York City. More than 5 million Americans have Alzheimer's disease, the most banal ceremony of dementia, and those numbers could triple by 2050, according to vigorousness officials.
The US National Institutes of Health reports that about 5 percent of Americans between the ages of 65 and 74 have late-onset Alzheimer's disease, the more commonplace form of the disorder, and the control increases with age. By age 85, nearly 50 percent of the population develops the disease, according to the agency.
Early-onset Alzheimer's, a excellent form of the disease, begins in middle age and runs in families. Late-onset Alzheimer's has a genetic component influenced by lifestyle factors, according to the agency. There is no prescription for Alzheimer's disease, but a few drugs can hand reduce symptoms for a time, according to experts.
German Scientists Have Found That Many Food Supplements For Weight Loss Are No Better Than Placebo
German Scientists Have Found That Many Food Supplements For Weight Loss Are No Better Than Placebo.
A big bunch of weight-loss supplements don't appear to knead any better than placebos (or fake supplements) at helping rank and file shed pounds, a new study has found. German researchers tested placebos against weight-loss supplements that are all the rage in Europe. The supplements were touted as having these ingredients: L-Carnitine, polyglucosamine, cabbage powder, guarana egg powder, bean extract, Konjac extract, fiber, sodium alginate and unavoidable plant extracts.
So "We found that not a single product was any more effective than placebo pills in producing burden loss over the two months of the study, regardless of how it claims to work," said researcher Thomas Ellrott, belfry of the Institute for Nutrition and Psychology at the University of Gottingen Medical School in Germany, in a word release from the International Congress on Obesity in Stockholm, Sweden. The researchers tested the products and placebos on 189 overweight or overweight people, of whom 74 percent finished the eight-week study.
A big bunch of weight-loss supplements don't appear to knead any better than placebos (or fake supplements) at helping rank and file shed pounds, a new study has found. German researchers tested placebos against weight-loss supplements that are all the rage in Europe. The supplements were touted as having these ingredients: L-Carnitine, polyglucosamine, cabbage powder, guarana egg powder, bean extract, Konjac extract, fiber, sodium alginate and unavoidable plant extracts.
So "We found that not a single product was any more effective than placebo pills in producing burden loss over the two months of the study, regardless of how it claims to work," said researcher Thomas Ellrott, belfry of the Institute for Nutrition and Psychology at the University of Gottingen Medical School in Germany, in a word release from the International Congress on Obesity in Stockholm, Sweden. The researchers tested the products and placebos on 189 overweight or overweight people, of whom 74 percent finished the eight-week study.
Wednesday 1 March 2017
Computer Simulation Of The New Look Of The Nose
Computer Simulation Of The New Look Of The Nose.
Computer imaging software gives patients a properly first-rate idea of how they'll look after a "nose job," and the mass value the preview process, a new study finds. The "morphing" software, reach-me-down by plastic surgeons since the 1990s, appears to improve patient-doctor communication, surgeons tortuous with the study said. "Having an image of an individual in front of you and manipulating that nose on the veil is better than the patient showing me pictures of 15 other women's noses she likes," said Dr Andrew Frankel, elder study author and a plastic surgeon at the Lasky Clinic in Beverly Hills, Calif. "It's her semblance and her nose".
Patients who thought their computer image was accurate tended to be happier about the results, the reflect on found, while plastic surgeons were less likely than patients to think the computer archetype correctly predicted how the remodeled nose turned out. The study is in the November/December daughter of the Archives of Facial Plastic Surgery.
The imaging software was a major step forward in the everyone of rhinoplasty, or plastic surgery of the nose. "Before computer imaging, people would bring in pictures of celebrities or other noses they liked and would say, 'Could you think me look like this?'" Frankel said.
But reassuring that was often impossible, plastic surgeons said. Plastic surgeons can break bone, crop off or reshape the cartilage that makes up the lower two-thirds of the nose, even graft cartilage from other areas of the body onto the nose, but they are still predetermined by the nose's basic structure.
And "I have to constantly communicate to the patient what are moderate expectations," said Dr Richard Fleming, a Beverly Hills plastic surgeon. "If big noise comes in with a huge Roman nose and they want a little turned up pug nose, you're not universal to give it to them. It cannot be accomplished".
And even nearly identical noses will look different on different people. "Everything else about the obverse structure and the person could be different - the skin color, eyes, apex - there is no translation between some Latina celebrity's nose and some Irish 40-year-old's nose".
Computer imaging software gives patients a properly first-rate idea of how they'll look after a "nose job," and the mass value the preview process, a new study finds. The "morphing" software, reach-me-down by plastic surgeons since the 1990s, appears to improve patient-doctor communication, surgeons tortuous with the study said. "Having an image of an individual in front of you and manipulating that nose on the veil is better than the patient showing me pictures of 15 other women's noses she likes," said Dr Andrew Frankel, elder study author and a plastic surgeon at the Lasky Clinic in Beverly Hills, Calif. "It's her semblance and her nose".
Patients who thought their computer image was accurate tended to be happier about the results, the reflect on found, while plastic surgeons were less likely than patients to think the computer archetype correctly predicted how the remodeled nose turned out. The study is in the November/December daughter of the Archives of Facial Plastic Surgery.
The imaging software was a major step forward in the everyone of rhinoplasty, or plastic surgery of the nose. "Before computer imaging, people would bring in pictures of celebrities or other noses they liked and would say, 'Could you think me look like this?'" Frankel said.
But reassuring that was often impossible, plastic surgeons said. Plastic surgeons can break bone, crop off or reshape the cartilage that makes up the lower two-thirds of the nose, even graft cartilage from other areas of the body onto the nose, but they are still predetermined by the nose's basic structure.
And "I have to constantly communicate to the patient what are moderate expectations," said Dr Richard Fleming, a Beverly Hills plastic surgeon. "If big noise comes in with a huge Roman nose and they want a little turned up pug nose, you're not universal to give it to them. It cannot be accomplished".
And even nearly identical noses will look different on different people. "Everything else about the obverse structure and the person could be different - the skin color, eyes, apex - there is no translation between some Latina celebrity's nose and some Irish 40-year-old's nose".
Subscribe to:
Posts (Atom)